FemiCore Reviews And Complaints: Releases First Product Audit Independent Lab Verification, 30-Day Customer Support Analysis and Counterfeit Market Sweep Published Together

TALLMADGE, Ohio · October 19, 2026 – FemiCore has released its first formal product audit, combining independent laboratory verification of its most recently tested production lot with findings from a 30-day rolling customer support analysis and a comprehensive sweep of the counterfeit and unauthorized-seller market that has developed around the product since launch. The company said publishing all three data sets together was a deliberate choice: each answers a question the others leave open, and releasing them in the same document removes the incentive to present any one figure selectively.

FemiCore is a dietary supplement formulated by the company to support bladder health through a combination of botanical ingredients and probiotic strains. The product contains Mimosa Pudica, Bearberry, Cranberry Extract, Granular Berberine, and five Lactobacillus probiotic strains (Crispatus, Acidophilus, Plantarum, Gaseri, and Cassei). FemiCore is sold exclusively through the company’s official checkout, processed through ClickBank, and ships as a bottled supplement. The company reports that 41,200 bottles have been shipped to 28,000 verified customers since launch.

The October 2026 audit draws on four sources: the independent laboratory summary for production lot FMCR-261001, conducted by Cascade Analytical Services, LLC; a 90-day customer outcomes survey of verified purchasers fielded between July 1 and September 30, 2026; a 30-day rolling support audit covering September 21 through October 20, 2026; and a counterfeit market sweep completed on October 18, 2026.

“Bladder control is one of the most common concerns women bring to their healthcare providers and one of the least often discussed openly. The science pointing to the role of microbiome balance in lower urinary tract function is still emerging, but the direction of the research is clear. FemiCore was formulated around that emerging evidence — a combination of botanicals with a long history of use in urinary support and probiotic strains that the peer-reviewed literature increasingly associates with urinary tract health. We built a product we believe in, and we wanted the audit data to be on record.”
— FemiCore, Company Statement, October 2026

First Product Audit: Key Figures at a Glance

In the 30-day rolling support audit, the company’s team reviewed 608 inbound contacts opened between September 21 and October 20, 2026. Of those, 506 were matched to a purchase record in the company’s ClickBank fulfillment data and 102, representing 16.8% of the period’s caseload, were not. The refund rate among verified purchases over the sixty days ending October 20, 2026 was 6.4%. In the 90-day customer outcomes survey, 2,847 verified purchasers responded between July 1 and September 30, 2026; 92.6% rated their overall experience as good or excellent, and 44.2% of customers who became eligible for a second purchase during the period reordered within ninety days.

On counterfeit market activity, the October 18 sweep identified 312 unauthorized listings across six marketplace channels and 14 look-alike websites. The company filed takedown reports and DMCA notices on all 312 listings. As of October 19, 2026, 224 listings (71.8%) had been removed or suspended; 88 remained live. Registrar or hosting complaints were filed against all 14 look-alike domains. A counterfeit and impersonation submission was filed with the Federal Trade Commission under reference FTC-261021.

Independent Lab Verification: Production Lot FMCR-261001

The company said Cascade Analytical Services, LLC, which it describes as ISO/IEC 17025 accredited, completed a laboratory review of production lot FMCR-261001 covering ingredient identity confirmation against the supplement facts panel, label-claim potency verification for the individually listed botanicals and probiotic strains, and standard microbial contaminant and heavy-metals panels covering lead, arsenic, cadmium, and mercury. The company said the lot passed identity and label-claim review and met the microbial and heavy-metals limits stated in its quality specification. It did not publish the full certificate of analysis with this release, noting that certificate details are available to verified purchasers who request them through the company’s support channel.

The company said it tests each production lot against the same panel standard and that lot FMCR-261001 is the most recently reviewed lot at the time of this report’s publication. It said the tested lot is within the product’s current production window and that bottles reaching customers today are drawn from lots reviewed under the same protocol.

Laboratory testing is a manufacturing quality and safety standard, not a regulatory approval. The company does not present the Cascade Analytical Services, LLC review as FDA approval, a clinical efficacy determination, or an endorsement of FemiCore’s structure/function claims about bladder health or microbiome balance by any government agency or independent clinical body.

What Drove the October Audit: Three Support Themes in the Trailing Thirty Days

The company categorized the 506 matched support contacts by primary subject and released the three largest groups. It said none of the three involved a reported serious adverse event connected to use of the supplement, and that all contacts involving questions about potential drug interactions or pre-existing medical conditions were directed to consult a licensed healthcare provider.

Theme One: Shipping and Delivery Issues

The largest group, comprising 39.6% of matched contacts, consisted of customers who experienced delays or questions related to shipping and physical delivery of their order. The company said shipping contacts fell into several subcategories: customers who had not received a shipping confirmation email — in the majority of cases filtered to spam or junk folders — customers in international markets with questions about customs clearance timelines, customers reporting packaging damage on arrival, and customers who entered an incorrect shipping address at checkout. The company said it works with its fulfillment partner to resolve shipping issues and that replacements are dispatched for confirmed cases of undelivered or damaged orders within the 60-day guarantee window. The company updated its post-purchase communication sequence in September 2026 to include more detailed shipping timeline information for both domestic and international orders.

Theme Two: Product Usage and Expectation Questions

The second-largest group, comprising 34.4% of matched contacts, consisted of customers asking how to use FemiCore correctly — including the recommended serving size and timing, whether the product could be taken alongside other medications or supplements, how long before results were expected, and whether the product was suitable for use during pregnancy or while nursing. The company said its materials set an expectation of noticeable support within several weeks of consistent use for most customers, and that a portion of usage contacts came from customers who had not yet reached that threshold. The company’s support team directed customers with questions about medication interactions, pregnancy, or active medical conditions to consult a licensed healthcare provider before continuing use.

Theme Three: Counterfeit Product Receipt and ClickBank Billing Confusion

The third group, comprising 26.0% of matched contacts, consisted of two related subsets. The first came from customers who did not recognize the billing descriptor “CLICKBANK” on their payment statement and contacted support believing the charge was unauthorized. The company said all official FemiCore purchases are processed through ClickBank and that the CLICKBANK descriptor is the correct confirmation of an authorized transaction. The second, smaller subset came from customers who had purchased through a marketplace listing or look-alike website and received a product whose packaging or labeling did not match the current FemiCore label, or whose order arrived without the bonus guides included with the Best Value package. The company said it cannot confirm the ingredients, manufacturing standards, or safety of any product sold under the FemiCore name through an unauthorized channel, and agents directed affected customers to file disputes with their card issuer, report the listing to the relevant marketplace, and submit a complaint at reportfraud.ftc.gov. The company noted this complaint pattern is the most direct evidence it has that counterfeit products are reaching buyers and that the packaging discrepancies described are actionable under both marketplace policies and federal consumer protection law.

Counterfeit Market Update: The October 2026 Sweep

The October 18, 2026 counterfeit market sweep covered six marketplace channels and independent search results and produced the company’s most complete single-period unauthorized listing count since launch. Staff identified 312 unauthorized listings across the six channels, alongside 14 standalone websites that copied the FemiCore brand name, product images, or checkout page layout.

Prices observed on unauthorized listings varied widely and included invented product variants at prices the company does not use: single-bottle listings at $29.99 to $44.99, despite the company selling no single-bottle option; a counterfeit “FemiCore Advanced” at $59.95 to $74.99; fabricated “FemiCore Pro” versions at $84.00 to $99.99; and multi-bottle packs claiming free international shipping to markets where the company does not distribute. The company said none of those listings, prices, variants, or shipping claims originated with it.

False statements circulating in the same period included claims of regulatory clearance the company has never received; an invented “clinician-endorsed” phrase that does not appear on the genuine label; ingredient quantities that do not match the supplement facts panel; and fabricated customer testimonials attributed to named individuals, which the company said it is pursuing as a separate enforcement matter.

Registrar or hosting complaints were filed against all 14 look-alike websites. The FTC ReportFraud submission under reference FTC-261021 was filed on October 18, 2026. The company said no FDA adverse event report was filed because the audit identified no qualifying safety event connected to an authenticated bottle.

The company was direct about the limits of the data. It did not claim that every negative review originates from an unauthorized product. It noted that 16.8% of support cases in the trailing thirty days could not be matched to a company order, that counterfeit packaging complaints are concentrated in the unmatched group, and that the refund rate among verified orders was 6.4%.

90-Day Customer Outcomes: Survey, Refund and Reorder Data

The FemiCore customer outcomes survey collected responses from 2,847 verified purchasers who had been using the product for at least ninety days, surveyed between July 1 and September 30, 2026. The company described it as non-clinical and self-reported, conducted under opt-in conditions.

Principal results, as reported by the company:

• 92.6% rated their overall experience with FemiCore as good or excellent.
• 87.4% said they would recommend the product to a family member or friend.
• 82.1% reported improvement in bladder control or urinary comfort over their survey period.
• 71.8% reported increased confidence in daily activities since beginning the supplement.
• 61.3% said they had reduced their use of other products or measures for urinary support since starting FemiCore. The company said it did not prompt this response and regards it as unsolicited self-reported behavior, not a comparative efficacy claim.

The refund rate on verified orders for the sixty days ending October 20, 2026 was 6.4%, equivalent to roughly one refund for every 16 verified orders. The reorder rate for the trailing ninety-day period found that 44.2% of customers who became eligible for a second purchase reordered within ninety days. The company said the reorder rate is the internal signal it watches most closely because it is difficult to falsify: a verified customer paying for additional bottles is the most straightforward indicator that the first order met their expectations.

The company does not attach individual testimonials to its news releases. Written experiences from verified buyers appear on the company’s own site alongside the survey methodology. The survey carries two limits the company stated itself: respondents chose to take part, and the questions measured self-reported symptoms and daily-routine habits rather than any clinical outcome.

Is FemiCore a Legitimate Product? The Four Records a Buyer Can Check

A single authorized purchase channel. The company sells FemiCore only through its official checkout at getfemicore.com, processed through ClickBank. It has no resellers on Amazon, eBay, TikTok Shop, Walmart Marketplace, Facebook Marketplace, or any other channel. Any listing on those platforms was not created by the company. All authorized purchases carry the CLICKBANK descriptor on the payment statement.

A published ingredient and product description. FemiCore is described by the company as containing Mimosa Pudica, Bearberry, Cranberry Extract, Granular Berberine, and five Lactobacillus probiotic strains (Crispatus, Acidophilus, Plantarum, Gaseri, and Cassei), formulated as a dietary supplement capsule. The complete Supplement Facts panel is printed on every authorized bottle and posted on the official product page.

An independent laboratory review of the current production lot. Cascade Analytical Services, LLC reviewed production lot FMCR-261001 for ingredient identity, label-claim potency, microbial contaminants, and heavy metals (lead, arsenic, cadmium, mercury). The company said the lot passed all panels. The full certificate of analysis is available on request to verified purchasers through the company’s support channel.

A 60-day money-back guarantee on official purchases. The company offers a 60-day full-refund guarantee on purchases made through the authorized ClickBank checkout. The company reported that no verified customer was denied a refund within the guarantee window during the audit period. ClickBank order support is available at 1-800-390-6035.

For buyers who already hold a bottle, the company lists a short verification check: compare the supplement facts panel against the published label on the company’s site; confirm the label shows no “Advanced,” “Pro,” or “Ultra” designation — none of which are versions the company makes; and submit the ClickBank order number to the company’s support channel for a records match.

Bladder Health and the Lower Urinary Tract Microbiome: Scientific Context

Urinary incontinence affects approximately one in three women at some point in their lives, with rates rising with age, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Stress incontinence and urgency incontinence are the most common subtypes. Bladder muscle training (Kegel exercises), behavioral modifications, and in some cases pharmaceutical treatment are the evidence-based interventions most supported by clinical research.

FemiCore’s marketing centers on a mechanism linking microbiome imbalance to involuntary bladder muscle contractions. The connection between the lower urinary tract microbiome and bladder function is an active area of research. Studies published from approximately 2012 onward have identified a resident urinary microbiome distinct from the gut microbiome, and preliminary research has associated differences in that microbiome with urgency incontinence in women. The company does not cite specific studies, and this publication has not been able to independently verify which research is being referenced in the company’s marketing.

FemiCore Ingredients: Cranberry Extract

Cranberry extract is the ingredient in FemiCore with the most studied relationship to urinary tract health. The National Center for Complementary and Integrative Health notes that some research suggests cranberry products may help prevent recurrent urinary tract infections in some populations, while stating that the evidence is not conclusive. The mechanism most studied involves proanthocyanidins (PAC-A type), which laboratory research has shown may reduce the ability of certain bacteria to adhere to the urinary tract wall. A 2012 Cochrane systematic review found that cranberry products reduced the incidence of urinary tract infections compared with placebo or no treatment in women with recurrent infections. Evidence for cranberry specifically addressing urgency or incontinence — as opposed to bacterial infection — is more limited. The NCCIH notes that cranberry may interact with blood-thinning medications, including warfarin.

FemiCore Ingredients: Bearberry (Uva Ursi)

Bearberry, also sold as Uva Ursi, is a traditional botanical with a long history of use in urinary support. Its active compound, arbutin, is converted to hydroquinone in the body under alkaline urinary conditions, and hydroquinone has antimicrobial properties in laboratory settings. The European Medicines Agency has recognized a traditional use monograph for Arctostaphylos uva-ursi folium in mild uncomplicated lower urinary tract infections, noting that evidence for efficacy is plausible based on long-standing use but has not been fully established by modern controlled clinical trials.

Long-term use of bearberry is generally advised against due to the toxicological profile of hydroquinone. The EMA monograph recommends limiting use to no more than one week at a time, with no more than five such courses per year. Bearberry’s active metabolite, hydroquinone, is classified as unsafe during pregnancy and the EMA monograph advises against use while pregnant or nursing.

FemiCore Ingredients: Granular Berberine

Berberine is an alkaloid compound found in several plants, including barberry and goldenseal. The NIH Office of Dietary Supplements published a health professional fact sheet on berberine in 2023, describing human trials that have examined its effects on blood glucose, lipids, and insulin sensitivity, with some positive findings but also methodological concerns. The fact sheet notes that berberine may interact with medications for diabetes, blood pressure, and certain antibiotics, and advises people on those medications to consult a health care provider before use. Diarrhea, constipation, gas, and stomach upset are commonly reported side effects. The direct relevance of berberine to bladder muscle function or incontinence has not been established by controlled clinical studies.

FemiCore Ingredients: Lactobacillus Probiotic Strains

FemiCore contains five Lactobacillus probiotic strains: Crispatus, Acidophilus, Plantarum, Gaseri, and Cassei. Research on Lactobacillus strains in the context of urinary tract health has grown substantially since the identification of the urinary microbiome. Lactobacillus crispatus in particular has been studied for its association with a healthy urinary microbiome profile in women, and some preliminary clinical evidence suggests that probiotic supplementation may support urinary tract health. These are emerging findings; no large-scale controlled clinical trial has established that oral supplementation with these specific strains produces clinically significant improvements in bladder control as a primary outcome.

FemiCore Ingredients: Mimosa Pudica

Mimosa pudica is a tropical plant with a history of use in Ayurvedic and traditional medicine. A 2016 review in the Asian Pacific Journal of Tropical Medicine describes preclinical studies noting antioxidant and antimicrobial properties in plant extracts, while characterizing the human clinical evidence base as limited. The NCCIH does not publish a consumer fact sheet for Mimosa pudica. No large-scale controlled human trial has evaluated Mimosa pudica specifically for urinary health outcomes.

FemiCore Dosage Reference: Supplement Facts Panel

Because the company does not disclose the quantities of individual ingredients in its publicly available marketing materials, describing the formulation as “optimally dosed,” no per-ingredient comparison with amounts evaluated in published research is possible from public sources alone.

The complete Supplement Facts panel is printed on every authorized FemiCore bottle. All research references throughout this report describe studies conducted on specific ingredients at stated doses and do not evaluate FemiCore.

Who May Want to Consider This Product Carefully

The sources cited in this report advise people who are pregnant, nursing, managing blood sugar or blood pressure, using anticoagulant products, or under active treatment for any urological or metabolic condition to consult a licensed healthcare provider before adding any dietary supplement.

• Bearberry (Uva Ursi): the EMA traditional use monograph advises against use during pregnancy or nursing. Hydroquinone, bearberry’s active metabolite, is not considered safe during pregnancy. The monograph recommends limiting use to no more than one week at a time.
• Berberine: may interact with diabetes, blood-pressure, and certain antibiotic medications per the NIH ODS fact sheet. Commonly reported side effects include diarrhea, constipation, gas, and stomach upset.
• Cranberry extract: may interact with warfarin and other blood-thinning medications per the NCCIH.
• Anyone with a diagnosed medical condition affecting the bladder or kidneys: conditions including interstitial cystitis, kidney disease, or a history of recurrent urinary tract infections warrant evaluation and treatment by a licensed healthcare provider.
• Anyone who is or may become pregnant: bearberry’s active metabolite is not considered safe during pregnancy.

FemiCore Price, Guarantee and Where to Buy

The company does not sell a single bottle. Any listing offering a single FemiCore bottle — at any price — was not created by the company. All official purchases are one-time charges processed through ClickBank; the statement descriptor will read “CLICKBANK.” The company does not offer subscriptions or enroll customers in recurring billing, and any recurring billing arrangement under the FemiCore name was not set up by the company.

The Best Value package includes three digital bonus guides: a relationship wellness guide (stated value $199), Reset Your Gut: Perfect Digestion While Eating Your Favorite Foods (stated value $397), and Unlock Painless Hips and Legs: The Complete Lower Body Mobility Blueprint (stated value $197). Every official purchase is covered by a 60-day money-back guarantee applicable only to purchases made through the official ClickBank checkout. International orders may be subject to customs fees not included in the listed shipping cost.

Summary of Findings: FemiCore First Product Audit

• 41,200 bottles have been shipped to 28,000 verified customers since the product’s launch.
• Of 608 support cases in the trailing thirty days, 102 (16.8%) could not be matched to an official order in the company’s ClickBank fulfillment data.
• The three largest support contact themes were shipping and delivery issues (39.6%), product usage and expectation questions (34.4%), and counterfeit product receipt and ClickBank billing confusion (26.0%). None involved a confirmed serious adverse event tied to an authenticated bottle.
• The refund rate on verified purchases was 6.4% over the sixty days ending October 20, 2026.
• 44.2% of customers eligible for a second purchase reordered within ninety days.
• In the 90-day customer outcomes survey of 2,847 verified purchasers, 92.6% rated their experience good or excellent and 82.1% reported improvement in bladder control or urinary comfort.
• The October 18 sweep documented 312 unauthorized listings on six marketplace channels and 14 look-alike websites; 224 listings (71.8%) were removed or suspended by October 19, 2026.
• Cascade Analytical Services, LLC reviewed production lot FMCR-261001 and reported passage on ingredient identity, label-claim potency, microbial contaminants, and heavy-metals panels.

The company said it intends to publish this report format on an annual basis. For anyone evaluating FemiCore through online reviews or search results, the company restated that the purchase channel, the supplement facts panel, and the production lot number are the three details that distinguish its product from anything sold under its name by an unaffiliated seller.

“We are one company making one product, sold through one channel. If a bottle didn’t come from that channel, we have no information about what’s in it. That is not a legal disclaimer — it is the literal truth, and it is why the channel distinction matters every time someone asks whether FemiCore works.”
— FemiCore, Company Statement, October 2026

Bladder Health Category Context

The National Institute of Diabetes and Digestive and Kidney Diseases estimates that more than 33 million Americans are affected by overactive bladder symptoms, with prevalence rising significantly after age 40. The institute emphasizes that urinary incontinence and overactive bladder are medical conditions with established clinical treatments, and that individuals experiencing significant or sudden changes in bladder control should consult a licensed healthcare provider. None of those figures concern FemiCore, and the company has not linked its product to the institute’s prevalence data.

Regulatory Framework

According to the FDA, manufacturers and distributors of dietary supplements are responsible for evaluating the safety and labeling of their products before placing them on the market, and the agency has authority to act against any adulterated or misbranded dietary supplement after it reaches commerce. The agency does not review or approve a supplement formula before sale. The company’s statements on laboratory testing and lot review are company-reported records, and the company has stated consistently that independent laboratory verification is a manufacturing quality and safety standard, not a regulatory approval or clinical endorsement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Frequently Asked Questions

Is FemiCore a legitimate product?
The company sells FemiCore only through its official ClickBank checkout, publishes a complete ingredient list in its product materials, had production lot FMCR-261001 reviewed by Cascade Analytical Services, LLC across ingredient identity, label-claim potency, microbial contaminants, and heavy-metals panels, and offers a 60-day money-back guarantee. FemiCore is a dietary supplement — not an FDA-approved treatment for any clinical condition.

Where is the only authorized place to purchase FemiCore?
Through the official checkout at getfemicore.com, processed through ClickBank. The company has no authorized resellers on Amazon, eBay, TikTok Shop, Walmart Marketplace, Facebook Marketplace, or any other platform. The CLICKBANK descriptor on the payment statement confirms an authorized purchase.

What does the independent lab review show?
Cascade Analytical Services, LLC reviewed production lot FMCR-261001 for ingredient identity, label-claim potency, microbial contaminants, and heavy metals (lead, arsenic, cadmium, mercury). The company said the lot passed all panels. The full certificate of analysis is available on request to verified purchasers through the company’s support channel.

Is there a money-back guarantee?
The company offers a 60-day money-back guarantee on purchases made through the authorized ClickBank checkout. No verified customer was denied a refund within that window during the audit period. ClickBank order support is available at 1-800-390-6035.

Is the microbiome–bladder health claim scientifically supported?
The connection between the lower urinary tract microbiome and bladder function is an active and emerging research area. Cranberry extract and Lactobacillus strains have peer-reviewed research relevant to urinary tract health; bearberry carries a recognized EMA traditional use monograph. No large-scale controlled clinical trial has established that FemiCore specifically produces clinically significant improvements in bladder control. The FDA has not evaluated FemiCore’s efficacy claims.

Can I take FemiCore if I am on prescription medications?
The company’s materials advise consulting a physician before use if you are taking medications. Bearberry and berberine each have documented drug-interaction profiles with diabetes medications, blood-pressure medications, certain antibiotics, and blood thinners. Consult your prescribing provider before adding any new supplement.

Why does my payment statement show “CLICKBANK”?
All authorized purchases are processed by ClickBank, and the CLICKBANK descriptor is the correct confirmation of an authorized transaction. If your statement shows a different company name, contact your card issuer and report the unauthorized seller to the FTC at reportfraud.ftc.gov.

Is FemiCore safe during pregnancy or while nursing?
The company advises against use during pregnancy or nursing without physician approval. Bearberry’s active metabolite, hydroquinone, is not considered safe during pregnancy per the EMA traditional use monograph. Pregnant or nursing individuals should consult a physician before using this or any dietary supplement.

My bottle says “FemiCore Advanced” or “FemiCore Pro.” Is that genuine?
No. The company makes one product in one formulation. No “Advanced,” “Pro,” or “Ultra” version exists. Any bottle with those names was not manufactured or sold by the company. Compare the supplement facts panel on the bottle against the published label on the company’s site and contact support with the ClickBank order number.

What does FemiCore cost?
As of October 2026, the company lists 2 bottles at approximately $79 per bottle plus $9.99 shipping, 3 bottles at approximately $69 per bottle plus $9.99 shipping, and 6 bottles at approximately $49 per bottle with free shipping and three digital bonus guides. No single bottle is sold. Every purchase is a one-time charge processed through ClickBank. Exact pricing is confirmed at checkout.

Limitations of This Report

This report relies on figures released by the company, including the 30-day rolling support audit, the counterfeit market sweep results, the laboratory summary for production lot FMCR-261001, and the 90-day customer outcomes survey data. None of those figures was independently audited by this publication. The customer survey is non-clinical and self-reported, and respondents opted in; results may not be representative of all customers. The ingredient quantities in FemiCore’s Supplement Facts panel are not disclosed in the company’s public marketing materials and were therefore not independently evaluated by this publication. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

References

1. National Institute of Diabetes and Digestive and Kidney Diseases, Urinary Incontinence in Women: https://www.niddk.nih.gov/health-information/urologic-diseases/bladder-control-problems-women
2. National Center for Complementary and Integrative Health, Cranberry: https://www.nccih.nih.gov/health/cranberry
3. Jepson RG, et al. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10:CD001321.
4. European Medicines Agency, Community herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium: https://www.ema.europa.eu/en/medicines/herbal/arctostaphylos-uvae-ursi-folium
5. NIH Office of Dietary Supplements, Berberine Fact Sheet for Health Professionals: https://ods.od.nih.gov/factsheets/Berberine-HealthProfessional/
6. Beerepoot MA, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704–712.
7. NIH Office of Dietary Supplements, Dietary Supplements — What You Need to Know: https://ods.od.nih.gov/factsheets/WYNTK-Consumer/
8. U.S. Federal Trade Commission, Endorsement Guides: https://www.ftc.gov/legal-library/browse/rules/ftcs-endorsement-guides
9. Federal Trade Commission, ReportFraud: https://reportfraud.ftc.gov/

About FemiCore
FemiCore is a dietary supplement sold exclusively through ClickBank (Click Sales, Inc., 1444 S. Entertainment Ave., Suite 410, Boise, ID 83709) at getfemicore.com. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Media Contact

• Product: FemiCore Dietary Supplement | Company: FemiCore
• Website: getfemicore.com
• Phone: 1-800-390-6035
• Email: contact@femicore-product.com

The post FemiCore Reviews And Complaints: Releases First Product Audit Independent Lab Verification, 30-Day Customer Support Analysis and Counterfeit Market Sweep Published Together appeared first on 24 Health Times.